|
"lu ys"的相關文件
顯示項目 1-44 / 44 (共1頁)
1
每頁顯示[10|25|50]項目
| 國家衛生研究院 |
2025-10-28 |
Deglycosylated PD-L1 is a biomarker for immune checkpoint blockade response: A real-world study in breast cancer patients in Taiwan
|
Wang, SC;Shen, YC;Pan, MR;Ou-Yang, F;Liao, TY;Liu, LC;Rau, KM;Lu, LS;Huang, CC;Dai, MS;Lu, YS;Chang, HW;Chang, H;Chang, KP;Wang, J;Tsai, CJ;Chou, IW;Li, HW;Cheng, WC;Li, TC;Cha, TL;Liao, GS;Chiu, CF;Huang, CS;Tseng, LM;Chiou, JF;Sheen-Chen, SM;Hou, MF;Hung, MC |
| 國家衛生研究院 |
2025-05-09 |
Unraveling the complex genetic landscape of OTOF-related hearing loss: A deep dive into cryptic variants and haplotype phasing
|
Lin, PH;Tsai, CY;Chiang, YT;Ho, CH;Lu, YS;Hsu, JSJ;Cheng, YF;Tsai, SF;Hsu, CJ;Chen, PL;Wu, CC |
| 國家衛生研究院 |
2024-09-10 |
Characteristics and transcriptional regulators of spontaneous epithelial-mesenchymal transition in genetically unperturbed patient-derived non-spindled breast carcinoma
|
Lien, HC;Yu, HC;Yu, WH;Lin, SF;Chen, TWW;Chen, IC;Hsiao, LP;Yeh, LC;Li, YC;Lo, C;Lu, YS |
| 國家衛生研究院 |
2019-11-25 |
Mortality of pregnancy following breast cancer diagnoses in Taiwanese women
|
Chuang, SC;Lin, CH;Lu, YS;Hsiung, CA |
| 國家衛生研究院 |
2019-05 |
Oral paclitaxel in the treatment of metastatic breast cancer (MBC) patients
|
Dai, MS;Chao, TC;Chiu, CF;Lu, YS;Shiah, HS;Wu, YY;Cheng, WH;Chan, WK;Hung, T;Hung, N;Cutler, D;Kwan, R;Kramer, D;Chao, TY |
| 臺大學術典藏 |
2018-09-10T06:55:45Z |
Differential expression of glucocorticoid receptor in carcinomas of the human digestive system
|
Lien, HC;Lu, YS;Shun, CT;Yao, YT;Chang, WC;Cheng, AL; Lien, H.-C. and Lu, Y.-S. and Shun, C.-T. and Yao, Y.-T. and Chang, W.-C. and Cheng, A.-L.; Lien, HC; CHIA-TUNG SHUN; HUANG-CHUN LIEN; Lu, YS; ANN-LII CHENG; Shun, CT; Yao, YT; Chang, WC; Cheng, AL |
| 國家衛生研究院 |
2018-08-02 |
Association of pregnancy and mortality in women diagnosed with breast cancer: A nationwide population based study in Taiwan
|
Chuang, SC;Lin, CH;Lu, YS;Hsiung, CA |
| 國家衛生研究院 |
2015-11-25 |
Associations between medical conditions and breast cancer risk in Asians: A nationwide population-based study in Taiwan
|
Chuang, SC;Wu, GJ;Lu, YS;Lin, CH;Hsiung, CA |
| 國立交通大學 |
2014-12-08T15:46:47Z |
Effects of aperture wall on the readout signal of erasable thermal phase change super resolution (EPSR) disks
|
Liu, JR; Lu, YS; Tien, CH; Tang, NY; Shieh, HPD |
| 國立交通大學 |
2014-12-08T15:04:38Z |
A PRECISION EXPERIMENT ON ELECTRONS, PHOTONS AND MUONS AT LHC
|
AZIZ, T; BOCK, R; BRAUNSCHWEIG, W; GEULIG, E; HILGERS, K; HILLEMANNS, H; KARPINSKI, W; KORNADT, O; KRENZ, W; LEHMANN, T; LINDEMANN, B; LUBELSMEYER, K; NIPPE, A; PANDOULAS, D; PEI, YJ; ROHNER, M; SCHMITZ, D; SCHOENTAG, M; SCHULZ, A; DRATZIG, V; SCHWENKE, J; SCHWERING, G; SIEDLING, R; SUBHANI, K; TOPOROWSKY, M; WALLRAFF, W; WEBER, A; XIAO, N; ZENG, Y; ZHOU, JF; ZITZEN, S; BLAISING, JJ; COIGNET, G; LEBEAU, M; SCHNEEGANS, M; CHIEN, CY; FISHER, PH; PAUL, T; PEVSNER, A; SPARTIOTIS, C; LI, H; WANG, WM; YU, BT; ZHOU, SM; BAI, JZ; CHEN, C; CHEN, GM; CHEN, HS; CHEN, SN; DAI, GL; FANG, C; HE, JT; HU, XG; JIN, BN; LAN, HB; LI, BM; LI, HT; LI, RB; LIU, HM; LU, YS; MA, JM; MAO, YF; QU, YH; SHEN, J; TANG, XW; TUNG, KL; WANG, F; WANG, JH; WEI, CL; WU, RJ; XIE, PP; YAN, J; YANG, CG; YANG, KS; YU, ZQ; ZHENG, GR; ZHU, GY; ZHANG, B; CHEN, WZ; CHEN, ZM; GUO, ZY; LIANG, YN; LIU, GL; NAN, DH; QU, JS; YIN, CY; ZHANG, CZ; BLOCK, F; BOSCHERINI, D; BRUNI, G; BRUNI, P; ROMEO, GC; CHIARINI, M; CINDOLO, F; CIRALLI, F; DAURIA, S; DELPAPA, C; FRASCONI, F; GIUSTI, P; IACOBUCCI, G; LEVI, G; MACCARONE, G; MARGOTTI, A; MASSAM, T; NANIA, R; PALMONARI, F; SARTORELLI, G; TIMELLINI, R; TZAMARIAS, S; BANERJEE, S; CHENDVANKAR, SR; DESHPANDE, PV; GANGULI, SN; GUPTA, SK; GURTU, A; MALHOTRA, PK; MAZUMDAR, K; RAGHAVAN, R; SHANKAR, K; SUDHAKAR, K; TONWAR, SC; AHLEN, S; MARIN, A; ZHOU, B; ANGELESCU, T; COTOROBAI, F; GHEORDANESCU, N; MIHUL, A; POP, D; BENCZE, GL; CSORGO, T; DENES, E; HOSVATTI, I; LEVAI, P; PRISZUYAK, M; TOTH, J; URBAN, L; ZIMANYI, J; KUMAR, KS; KUNIN, A; SCOTT, I; STRAUCH, K; ANDERSON, AL; BECKER, U; BERGES, P; BURGER, JD; CAPELL, M; CHANG, YH; CHEN, J; CHEN, M; CHUNG, S; CLARE, L; CLARE, R; DAI, TS; EPPLING, FJ; KLIMENTOV, A; KOUTSENKO, V; KRAMER, T; LEBEDEV, A; LUCKEY, D; RUBBIA, A; SARAKINOS, MS; SHOTKIN, S; SMITH, B; STEUER, M; TING, SCC; TING, SM; WYSLOUCH, B; GANTMAHER, V; GRAZJILIS, V; KLASSEN, N; OSSIPYAN, Y; SCHEGELEV, I; TIMOFEEV, V; CHEN, A; LIN, WT; BARILLARI, T; SCHIOPPA, M; SUSINNO, G; ADRIANI, O; CARTACCI, AM; CIANCAGLINI, G; CIVININI, C; DALESSANDRO, R; GALLO, E; MESCHINI, M; POJIDAEV, V; SPILLANTINI, P; WANG, YF; ANZIVINO, G; DEPASQUALE, S; VOTANO, L; ALCARAZ, J; ANSELMO, F; BARILLERE, R; BRUGNOLA, G; COLINO, N; DESALVO, R; FELCINI, M; FORD, P; GERWIG, H; HERVE, A; INNOCENTE, V; LACOMMARE, G; LARSEN, H; LAURENTI, G; LECOQ, P; LEGOFF, JM; MARINO, M; NEMOZ, C; PIERI, M; SALICIO, J; WILLIAMS, C; WITTGENSTEIN, F; ZICHICHI, A; BOURQUIN, M; AYAD, R; BENCHEICK, B; CAI, XD; CHATURVEDI, UK; CHEN, WY; CUI, XT; CUI, XY; DOVA, MT; GU, C; HASAN, AH; HATZIFOTIADOU, D; HE, HL; HU, G; KHAN, RA; KAUR, M; KHOKHAR, S; VALVERDE, JL; FLORIAN, EL; LIN, Q; LIU, LB; MI, Y; MIR, Y; MOULAI, NE; NIAZ, MA; QIAN, S; QURESHI, KN; REN, Z; RIZVI, HA; SEHGAL, R; SHABELSKI, YM; SUN, JY; SUN, LZ; SYED, AA; VIKAS, P; VIKAS, U; WADHWA, M; WANG, KL; WANG, ZM; WU, SX; XIA, XM; YANG, CY; YANG, G; YE, CH; YE, Q; YE, Y; YOU, JM; YUNUS, N; ZAMORA, GY; ZENG, M; ZHANG, ZP; ZHAO, M; DING, ZS; GE, MZ; HAN, GY; JIN, M; TANG, Y; WANG, R; YU, CW; ZHANG, XS; AN, Q; CHEN, HF; GAO, Q; GONG, ZF; GU, CH; JIANG, Y; LI, C; LIN, ZY; LIU, YY; LU, WZ; MA, WG; WANG, CR; WU, J; XU, ZZ; YANG, BZ; YE, JB; YE, SX; ZHOU, MH; SU, S; LEE, YY; NI, WT; YANG, YC; YEH, SC; YEN, HC; TAKAHASHI, Y; CHEN, HC; HAN, JR; HE, M; JIANG, MH; LI, Q; ZHANG, NJ; ZHANG, XY; ROSSELET, P; LEBRUN, P; MARTIN, JP; AGUILARBENITEZ, M; ARCE, P; BERDUGO, J; BURGOS, C; CERRADA, M; FERNANDEZ, D; FERNANDEZ, G; GARCIAABIA, P; GONZALEZ, E; MANA, C; MARTINEZLASO, L; RODRIGUEZ, FJ; ROMERO, L; SALICIO, JM; WILLMOTT, C; BASCHIROTTO, A; BOSETTI, M; CASTELLO, R; PENSOTTI, S; RANCOITA, PG; RATTAGGI, M; TERZI, G; AKIMOV, DY; AREFIEV, A; BOLOZDYNYA, AI; CHURAKOV, DL; GALAKTIONOV, Y; KOLOTAEV, Y; MALININ, A; PLYASKIN, V; ROZJKOV, A; SHUMILOV, E; SHOUTKO, V; VETLITSKY, I; VOROBIEV, I; BRAGIN, LA; CHERNOPLEKOV, N; KARPUSHOV, I; KLIMENKO, E; LELEKHOV, S; MALOFEEV, A; MOKHNATUK, V; NOVIKOV, S; VELIKHOV, E; ALOISIO, A; ALVIGGI, MG; BRAMBILLA, E; CARLINO, G; DEASMUNDIS, R; LANZANO, S; LISTA, L; PAOLUCCI, P; PATRICELLI, S; PICCOLO, D; SCIACCA, C; RAZIS, P; SEGUINOT, J; YPSILANTIS, T; GRATTA, G; GRUENEWALD, M; KIRKBY, D; MOUNT, R; NEWMAN, H; SHI, XR; TULLY, C; ZACCARDELLI, C; ZHU, RY; BATTISTON, R; BILEI, GM; CARIA, M; CHECCUCI, B; EASO, S; KRASTEV, V; PAULUZZI, M; SERVOLI, L; WANG, S; CIFARELLI, L; DENES, P; GUPTA, V; PIROUE, PA; STONE, H; STICKLAND, DP; WRIGHT, D; BARONE, L; BORGIA, B; CESARONI, F; DENOTARISTEFANI, F; DIEMOZ, M; DIONISI, C; FALCIANO, S; LEONARDI, E; LONGO, E; LUCI, C; LUMINARI, L; MIRABELLI, G; ORGANTINI, G; RESCIGNO, M; VALENTE, E; ANDREEV, V; ALKAHAZOV, G; BYKOV, A; KAPINOS, P; KIM, V; TSAREGORODTSEV, A; VOROBIEV, A; ZALITE, Y; SHEN, H; WU, WM; PAN, H; QIAN, C; SI, C; XIE, S; XU, B; YANG, W; ZHANG, S; FANG, XL; FENG, CD; FENG, XQ; GAO, HX; GAO, M; GU, PX; GUO, JK; HU, GQ; HU, YL; HUA, SK; LI, PJ; QI, ZD; SHEN, DZ; SHI, EW; SU, WT; WANG, XX; WEI, ZY; XIE, YY; XU, L; XUE, ZL; YAN, DS; YIN, ZW; YUAN, XL; ZHANG, YF; ZHAO, GM; ZHAO, YL; ZHONG, WZ; ZHOU, RM; WALENTA, AH; SHIVAROV, N; CHOI, MT; KIM, JK; KIM, YG; KIM, SC; SON, D; HSU, LS; LIN, WL; DIBITONTO, D; PENNINGTON, T; BUJAK, A; CARMONY, DD; GUTAY, LJ; MCMAHON, T; SPRINGFELLOW, BC; ANDERHUB, H; BEHNER, F; BEHRENS, J; BETEV, B; BILAND, A; DHINA, M; FABER, G; FREUDENREICH, K; HANSLI, M; HOFER, H; HORVATH, I; JONGMANNS, M; LECOMTE, P; LECOULTRE, P; MACDERMOTT, M; MAOLINBAY, M; MARCHESINI, P; MCNALLY, D; NESSITEDALDI, F; NEYER, C; PARADISO, J; PAUSS, F; POHL, M; RAHALCALLOT, G; REN, D; SCHOLZ, N; ROSER, U; RYKACZEWSKI, H; SUTER, H; ULBRICHT, J; VIERTEL, G; VONGUNTEN, HP; WALDMEIER, S; WEBER, J; ZEMP, P |
| 國家衛生研究院 |
2014-10 |
The association between medical history and breast cancer risk: A nationwide population-based case-control study using claim data
|
Chuang, SC;Wu, GJ;Lu, YS;Lin, CH;Hsiung, CA |
| 臺北醫學大學 |
2014 |
Distinct Clinicopat?hological Features and Prognosis of Emerging Young Female Breast Cancer in an East Asian Country: A Nationwide Cancer Registry-b?ased Study
|
Lin, CH;Chuang, PY;Chiang, CJ;Lu, YS;Cheng, AL;Huang, CS;Lai, MS;You, SL;Tang, CH |
| 國家衛生研究院 |
2011-05 |
Lack of compensatory pAKT activation and eIF4E phosphorylation of lymphoma cells towards mTOR inhibitor, RAD001
|
Kuo, SH;Hsu, CH;Chen, LT;Lu, YS;Lin, CH;Yeh, PY;Jeng, HJ;Gao, M;Yeh, KH;Cheng, AL |
| 中國醫藥大學 |
2011-05 |
Cisplatin as an active treatment in zoledronate-refractory hypercalcemia
|
林柏翰(Po-Han Lin); 邱昌芳(Chang-Fang Chiu); (Lu, YS)* |
| 中國醫藥大學 |
2010-07 |
Vinorelbine plus 24-hour infusion of high-dose 5-fluorouracil and leucovorin as effective palliative chemotherapy for breast cancer patients with acute disseminated intravascular coagulation.
|
林柏翰(Po-Han Lin); (Lu YS); (Lin CH); (Chang DY); (Huang CS); (Cheng AL); (Yeh KH)* |
| 國家衛生研究院 |
2009-09-15 |
Induction of Bim expression contributes to the antitumor synergy between sorafenib and mitogen-activated protein kinase/extracellular signal-regulated kinase kinase inhibitor CI-1040 in hepatocellular carcinoma
|
Ou, DL;Shen, YC;Liang, JD;Liou, JY;Yu, SL;Fan, HH;Wang, DS;Lu, YS;Hsu, C;Cheng, AL |
| 國家衛生研究院 |
2009-06 |
Molecular subtypes of breast cancer emerging in young women in Taiwan: Evidence for more than just westernization as a reason for the disease in Asia
|
Lin, CH;Liau, JY;Lu, YS;Huang, CS;Lee, WC;Kuo, KT;Shen, YC;Kuo, SH;Lan, C;Liu, JM;Kuo, WH;Chang, KJ;Cheng, AL |
| 國家衛生研究院 |
2009-04-24 |
Bortezomib overcomes tumor necrosis factor-related apoptosis-inducing ligand resistance in hepatocellular carcinoma cells in part through the inhibition of the phosphatidylinositol 3-kinase/Akt pathway
|
Chen, KF;Yeh, PY;Hsu, C;Hsu, CH;Lu, YS;Hsieh, HP;Chen, PJ;Cheng, AL |
| 國立臺灣大學 |
2008-11 |
OSU-03012, a novel celecoxib derivative, induces reactive oxygen species-related autophagy in hepatocellular carcinoma.
|
Gao, M; Yeh, PY; Lu, YS; Hsu, CH; Chen, KF; Lee, WC; Feng, WC; Chen, CS; Kuo, ML; Cheng, AL |
| 國立臺灣大學 |
2008-11 |
NF-kappaB p50 promotes tumor cell invasion through negative regulation of invasion suppressor gene CRMP-1 in human lung adenocarcinoma cells.
|
Gao, M; Yeh, PY; Lu, YS; Chang, WC; Kuo, ML; Cheng, AL |
| 國家衛生研究院 |
2008-08 |
Down-regulation of phospho-Akt is a major molecular determinant of bortezomib-induced apoptosis in hepatocellular carcinoma cells
|
Chen, KF;Yeh, PY;Yeh, KH;Lu, YS;Huang, SY;Cheng, AL |
| 國立臺灣大學 |
2008-06 |
Dose variation and regimen modification of adjuvant chemotherapy in daily practice affect survival of stage I-II and operable stage III Taiwanese breast cancer patients.
|
Kuo, SH; Lien, HC; You, SL; Lu, YS; Lin, CH; Chen, TZ; Huang, CS. |
| 國立臺灣大學 |
2008-06 |
The CYP19 TTTA repeat polymorphism is related to the prognosis of premenopausal stage I-II and operable stage III breast cancers.
|
Huang, CS; Kuo, SH; Lien, HC; Yang, SY; You, SL; Shen, CY; Lin, CH; Lu, YS; Chang, KJ. |
| 國立臺灣大學 |
2008-02 |
Differential expression of glucocorticoid receptor in carcinomas of the human digestive system
|
Lien, HC; Lu, YS; Shun, CT; Yao, YT; Chang, WC; Cheng, AL |
| 國家衛生研究院 |
2007-06-01 |
Histone deacetylase inhibitors sensitize prostate cancer cells to agents that produce DNA double-strand breaks by targeting Ku70 acetylation
|
Chen, CS; Wang, YC; Yang, HC; Huang, PH; Kulp, SK; Yang, CC; Lu, YS; Matsuyama, S; Chen, CY; Chen, CS |
| 國立臺灣大學 |
2007-03 |
Histone deacetylase inhibitors sensitize prostate cancer cells to agents that produce DNA double-strand breaks by targeting Ku70 acetylation.
|
Chen, CS; Wang, YC; Yang, HC; Huang, PH; Kulp, SK; Yang, CC; Lu, YS; Matsuyama, S; Chen, CY; Chen, CS |
| 國立臺灣大學 |
2007-02 |
A phase II trial of weekly paclitaxel and high-dose 5-fluorouracil plus leucovorin in patients with chemotherapy-pretreated metastatic breast cancer.
|
Lin, CC; Cheng, AL; Hsu, CH; Lu, YS; Hsu, C; Kun-Huei, Yeh; Wu, CY; Huang, CS; Yang, CH. |
| 國立臺灣大學 |
2007-02 |
A phase II trial of weekly paclitaxel and high-dose 5-fluorouracil plus leucovorin in patients with chemotherapy-pretreated metastatic breast cancer.
|
Lin, CC; Cheng, AL; Hsu, CH; Lu, YS; Hsu, C; Kun-Huei, Yeh; Wu, CY; Huang, CS; Yang, CH. |
| 國立臺灣大學 |
2006-12 |
Effects of glucocorticoids on the growth and chemosensitivity of carcinoma cells are heterogeneous and require high concentration of functional glucocorticoid receptors.
|
Lu, YS; Lien, HC; Yeh, PY; Yeh, KH; Kuo, ML; Kuo, SH; Cheng, AL. |
| 國家衛生研究院 |
2006-05 |
Phase I study of biweekly gemcitabine followed by oxaliplatin and simplified 48-h infusion of fluorouracil/leucovorin for advanced pancreatic cancer
|
Ch'ang, HJ; Wang, CC; Cheng, AL; Hsu, C; Lu, YS; Chang, MC; Lin, JT; Wang, HP; Shiah, HS; Liu, TW; Chang, JY; Whang-Peng, J; Chen, LT |
| 國家衛生研究院 |
2006-02 |
Glucocorticoids enhance cytotoxicity of cisplatin via suppression of NF-kappa B activation in the glucocorticoid receptor-rich human cervical carcinoma cell line SiHa
|
Lu, YS; Yeh, PY; Chuang, SE; Gao, M; Kuo, ML; Cheng, AL |
| 國立臺灣大學 |
2005-10 |
Effects of glucocorticoids on the growth and chemosensitivity of carcinoma cells are heterogeneous and require high concentration of functional glucocorticoid receptors.
|
Lu, YS; Lien, HC; Yeh, PY; Kun-Huei, Yeh; Kuo, ML; Kuo, SH; Cheng, AL |
| 國家衛生研究院 |
2005-09-14 |
Long-term hepatic consequences of chemotherapy-related HBV reactivation in lymphoma patients
|
Su, WP;Wen, CC;Hsiung, CA;Su, IJ;Cheng, AL;Chang, MC;Tsao, CJ;Kao, WY;Uen, WC;Hsu, CH;Lu, YS;Tien, HF;Chao, TY;Chen, LT;Whang-Peng, J;Chen, PJ |
| 國立臺灣大學 |
2005-08 |
Phase II study of weekly paclitaxel and 24-hour infusion of high-dose 5-fluorouracil and leucovorin in the treatment of recurrent or metastatic gastric cancer.
|
Yeh, KH; Lu, YS; Hsu, CH; Lin, JF; Hsu, C; Kuo, SH; Li, SJ; Cheng, AL. |
| 國立臺灣大學 |
2005-08 |
Phase II study of weekly paclitaxel and 24-hour infusion of high-dose 5-fluorouracil and leucovorin in the treatment of recurrent or metastatic gastric cancer.
|
Yeh, KH; Lu, YS; Hsu, CH; Lin, JF; Hsu, C; Kuo, SH; Li, SJ; Cheng, AL. |
| 國立臺灣大學 |
2005-06 |
Phase II study of weekly vinorelbine and 24-hour infusion of high-dose 5-fluorouracil plus leucovorin as first-line treatment of advanced breast cancer.
|
Yeh, KH; Lu, YS; Hsu, CH; Lin, JF; Chao, HJ; Huang, TC; Chung, CY; Chang, CS; Cheng, AL. |
| 國立臺灣大學 |
2005-06 |
Phase II study of weekly vinorelbine and 24-hour infusion of high-dose 5-fluorouracil plus leucovorin as first-line treatment of advanced breast cancer.
|
Yeh, KH; Lu, YS; Hsu, CH; Lin, JF; Chao, HJ; Huang, TC; Chung, CY; Chang, CS; Cheng, AL. |
| 國家衛生研究院 |
2005-03-28 |
Phase II study of weekly vinorelbine and 24-h infusion of high-dose 5-fluorouracil plus leucovorin as first-line treatment of advanced breast cancer
|
Yeh, KH; Lu, YS; Hsu, CH; Lin, JF; Chao, HJ; Huang, TC; Chung, CY; Chang, CS; Yang, CH; Cheng, AL |
| 國家衛生研究院 |
2005 |
Phase II study of weekly paclitaxel and 24-hour infusion of high-dose 5-fluorouracil and leucovorin in the treatment of recurrent or metastatic gastric cancer
|
Yeh, KH; Lu, YS; Hsu, CH; Lin, JF; Hsu, C; Kuo, SH; Li, SJ; Cheng, AL |
| 國家衛生研究院 |
2004-05-04 |
Weekly gemcitabine plus 24-h infusion of high-dose 5-fluorouracil/leucovorin for locally advanced or metastatic carcinoma of the biliary tract
|
Hsu, C; Shen, YC; Yang, CH; Yeh, KH; Lu, YS; Hsu, CH; Liu, HT; Li, CC; Chen, JS; Wu, CY; Cheng, AL |
| 國立臺灣大學 |
2004-05 |
Phase II study of combination doxorubicin, interferon-alpha, and high-dose tamoxifen treatment for advanced hepatocellular carcinoma.
|
Lu, YS; Hsu, C; Li, CC; Kuo, SH; Kun-Huei, Yeh; Yang, CH; Hsu, CH; Wu, CY; Cheng, AL. |
| 國立臺灣大學 |
2004-05 |
Weekly gemcitabine plus 24-h infusion of high-dose 5-fluorouracil/leucovorin for locally advanced or metastatic carcinoma of the biliary tract.
|
Hsu C; Shen YC; Yang CH; Kun-Huei Yeh; Lu YS; Hsu CH; Liu HT; Li CC; Chen JS; Wu CY; Cheng AL |
| 臺大學術典藏 |
2004-05 |
Weekly gemcitabine plus 24-h infusion of high-dose 5-fluorouracil/leucovorin for locally advanced or metastatic carcinoma of the biliary tract.
|
Hsu C;Shen YC;Yang CH;Kun-Huei Yeh;Lu YS;Hsu CH;Liu HT;Li CC;Chen JS;Wu CY;Cheng AL; Hsu C; Shen YC; Yang CH; Kun-Huei Yeh; Lu YS; Hsu CH; Liu HT; Li CC; Chen JS; Wu CY; Cheng AL |
| 國家衛生研究院 |
2002-05-01 |
Basal levels and patterns of anticancer drug-induced activation of nuclear factor-kappa B (NF-kappa B), and its attenuation by tamoxifen, dexamethasone, and curcumin in carcinoma cells
|
Chuang, SE; Yeh, PY; Lu, YS; Lai, GM; Liao, CM; Gao, M; Cheng, AL |
顯示項目 1-44 / 44 (共1頁)
1
每頁顯示[10|25|50]項目
|
